Eton Pharmaceuticals Licenses and Initiates ET-900 Program
ET-900 will evaluate mecasermin, the active ingredient in Eton’s INCRELEX, for infantile and epileptic spasms.
Story updates
11:52:29 AM UTC
SquawkNews
Eton licensed Baylor College of Medicine patent rights covering IGF-1 use in spasms and is advancing